ReviewFrontiers in oncology2021
Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.
- Systematic Review of PET/CT Utilization in Breast Implant-Associated Anaplastic Large Cell Lymphoma.Medicina (Kaunas, Lithuania) · 2025Pooled it
- Primary Breast Implant-Associated Squamous Cell Carcinoma: A Proposal for a Better Surgical Approach and Clinical Staging System Based on Tumour Characteristics.Annals of surgical oncology · 2025Pooled it
- Breast Implant Capsule-Associated Squamous Cell Carcinoma: A Systematic Review and Case Presentation.Aesthetic plastic surgery · 2024Pooled it
- From Case Reports to Molecular Insight: Examining the Outcomes and Underlying Mechanisms of Squamous Cell Carcinoma in Breast Implant Patients-A Systematic Review.International journal of molecular sciences · 2024Pooled it
- Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.Breast (Edinburgh, Scotland) · 2022Guideline
- Microbial Contamination-Mediated Inflammation Is a Major Contributor of Breast Implant Complications: Prospective Analysis of 631 Samples.Journal of clinical medicine · 2026Article
- Adverse Event Reports and Safety Measures for Breast Implant-associated Anaplastic Large Cell Lymphoma in Japan.Plastic and reconstructive surgery. Global open · 2026Article
- Epidemiology of mature T-cell and NK-cell neoplasms: east and west.The Lancet regional health. Western Pacific · 2025Review
- Pro-Inflammatory Response to Macrotextured Silicone Implant Wear Debris.Tribology letters · 2025Article
- A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan.Surgical case reports · 2024Article
- Breast implant surface topography triggers a chronic-like inflammatory response.Life science alliance · 2024Article
- Practice Trends in the Management of Asymptomatic Breast Reconstruction Patients with Textured Implants: A Survey Analysis.Plastic and reconstructive surgery. Global open · 2023Article
- Breast implant-associated anaplastic large cell lymphoma presenting as a breast mass: A case report and literature review.International journal of surgery case reports · 2023Article
- Breast Implant-Associated Tumors.Geburtshilfe und Frauenheilkunde · 2023Article
- First Case Report of Breast Implant Associated-Anaplastic Large Cell Lymphoma from India: Are We Ready?Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India · 2023Article
- The Role of Microorganisms in the Development of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Pathogens (Basel, Switzerland) · 2023Review
- Review
- Reverse strategy to locally advanced breast implant-associated anaplastic large cell lymphoma: A case report.Frontiers in oncology · 2022Article
- Comparison of Formation of Capsule Among Different Breast Silicone Implants.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is an uncommon type of T-cell lymphoma. Although with a low incidence, the epidemiological data raised the biosafety and health concerns of breast reconstruction and breast augmentation for BIA-ALCL. Emerging evidence confirms that genetic features, bacterial contamination, chronic inflammation, and textured breast implant are the relevant factors leading to the development of BIA-ALCL. Almost all reported cases with a medical history involve breast implants with a textured surface, which reflects the role of implant surface characteristics in BIA-ALCL. With this review, we expect to highlight the most significant features on etiology, pathogenesis, diagnosis, and therapy of BIA-ALCL, as well as we review the physical characteristics of breast implants and their potential pathogenic effect and hopefully provide a foundation for optimal choice of type of implant with minimal morbidity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.